Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests
Sfrisi, C.; Cocco, G.
La Clinica Terapeutica 111(2): 159-167
1984
ISSN/ISBN: 0009-9074 PMID: 6239739 Document Number: 223582
Document emailed within 1 workday
Related Documents
Follath, F. 1992: New positive inotropic drugs in acute and chronic heart failure Schweizerische Rundschau für Medizin Praxis 81(21): 704-707Michel, D. 1991: Positive inotropic substances. Possible use in heart failure in the aged Fortschritte der Medizin 109(25): 496-499
Lechat, P. 1989: Treatment of chronic heart failure with positive inotropic agents Therapie 44(6): 437-445
Kabela, E.; Michaels, D.C.; Felice, E.L. 1979: Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation Archivos del Instituto de Cardiologia de Mexico 49(5): 892-907
Wollschläger, H.; Drexler, H.; Löllgen, H.; Just, H. 1981: The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure Arzneimittel-Forschung 31(1a): 248-250
Goenen, M.J. 1986: New inotropic-vasodilating drugs in acute and chronic heart failure Annales de Medecine Interne 137(3): 229-234
Ikram, H.; Nicholls, M.G.; Fitzpatrick, M.A.; Crozier, I.G. 1986: ACE inhibitors or inotropic drugs after diuretics in heart failure--a personal critique Postgraduate Medical Journal 62(Suppl 1): 176-178
Martínez Martínez, J.A.; Salvati, A.; Suárez, L.D. 1986: Push of inotropic drugs in the treatment of refractory chronic cardiac insufficiency Medicina 46(3): 363-364
De Keulenaer, G.W.; Andries, L.J.; Sys, S.U.; Brutsaert, D.L. 1995: Endothelin-mediated positive inotropic effect induced by reactive oxygen species in isolated cardiac muscle Circulation Research 76(5): 878-884
Hoeksel, S.A.; Blom, J.A.; Jansen, J.R.; Maessen, J.G.; Schreuder, J.J. 1999: Automated infusion of vasoactive and inotropic drugs to control arterial and pulmonary pressures during cardiac surgery Critical Care Medicine 27(12): 2792-2798
Morano, I.; Piazzesi, G.; Rüegg, J.C. 1988: Myofibrillar calcium sensitivity modulation: influence of light chain phosphorylation and positive inotropic drugs on skinned frog skeletal muscle Advances in Experimental Medicine and Biology 226: 129-137
Heinzl, B.S. 1986: 200 years of digitalis. Controversies in the therapy of heart failure Medizinische Monatsschrift für Pharmazeuten 9(2): 42-46
Tavazzi, L. 2003: The inotropic therapy of decompensated heart failure revised. Introduction Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4 Suppl. 2: 3s-6s
Lechat, P. 1997: Beta-blockers and new drugs for cardiac failure La Revue du Praticien 47(19): 2131-2134
Hua, W.; Ding, L.-g.; Zhang, S.; Chen, K.-p.; Wang, J.; Wang, F.-z. 2010: Usefulness of previsualization of the cardiac venous system by 64-slice computed tomography in patients with heart failure underwent cardiac resynchronization therapy Zhonghua Xin Xue Guan Bing Za Zhi 38(7): 610-613
Pratap, V.K.; Singh, S.; Singh, S.N.; Saxena, H.; Nath, K. 1974: Acute phase "reactant" tests in congestive cardiac failure to assess the presence of fresh rheumatic activity Journal of the Association of Physicians of India 22(2): 143-151
Asanoi, H. 2003: Positive inotropic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(5): 827-832
Renard, M.; Jacobs, P.; Melot, C.; Dresse, A.; Bernard, R. 1984: Sulmazole: a new positive inotropic agent Annales de Cardiologie et d'Angeiologie 33(4): 219-222
Paukstadt, W. 1999: Resistance tests to improve therapy. more specific use of AIDS drugs MMW Fortschritte der Medizin 141(37): 18
Scholz, H.; Dieterich, H.A.; Schmitz, W. 1991: Mechanism of the positive inotropic effect of phosphodiesterase inhibitors Zeitschrift für Kardiologie 80(Suppl 4): 1-6